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ABSTRACT
PHF8 is a histone demethylase associated with
X-linked mental retardation. It has been described
as a transcriptional co-activator involved in cell
cycle progression, but its physiological role is still
poorly understood. Here we show that PHF8
controls the expression of genes involved in cell
adhesion and cytoskeleton organization such as
RhoA, Rac1 and GSK3b. A lack of PHF8 not only
results in a cell cycle delay but also in a disorganized
actin cytoskeleton and impaired cell adhesion. Our
data demonstrate that PHF8 directly regulates the
expression of these genes by demethylating
H4K20me1 at promoters. Moreover, c-Myc transcrip-
tion factor cooperates with PHF8 to regulate the
analysed promoters. Further analysis in neurons
shows that depletion of PHF8 results in down-
regulation of cytoskeleton genes and leads to a
deficient neurite outgrowth. Overall, our results
suggest that the mental retardation phenotype
associated with loss of function of PHF8 could be
due to abnormal neuronal connections as a result
of alterations in cytoskeleton function.
INTRODUCTION
X-linked mental retardation (XLMR) is a highly diverse
group of cognitive disorders. The high incidence of XLMR
makes this disorder an important problem in medicine
(1,2). A strikingly large number of genes mutated in
XLMR encode for regulators of chromatin structure
(2,3). One of these is the gene that codes for PHF8, a
histone demethylase (HDM) (4–6). PHF8 belongs to a
family of plant homeodomain (PHD) ﬁnger-containing
HDMs which in humans is formed by PHF2, PHF8 and
KIAA1718. These proteins contain an N-terminal PHD
and a Jumonji-C (JmjC) domain (7). Deletions and point
mutations in the PHF8 JmjC domain lead to Siderius–
Hamel syndrome, mild XLMR with cleft lip and/or a
cleft palate (CL/P) (4,8–10).
PHF8 binds through its PHD to H3K4me3 nucleo-
somes at the transcription start site (TSS) regions of
active promoters (11–14). Moreover, PHF8 catalytic
activity removes mono- and dimethyl-lysine 9 and 27 on
histone H3 and monomethyl-lysine 20 on histone H4
(11,12,14,15). All these are repressive histone modiﬁca-
tions, suggesting that PHF8-mediated removal of these
marks leads to transcriptional activation. In line with
this, knockdown (KD) of PHF8 leads to down-regulation
of several genes (11,12). Interestingly, some PHF8 target
genes are involved in XLMR, such as JARID1C, or in
neural development, such as MSX1 (11,16). Moreover,
KD of the PHF8 homolog in zebraﬁsh causes brain and
craniofacial developmental anomalies (13,16) and alters
neuronal differentiation of murine P19 cells (17). In
addition, loss of the PHF8 homolog in Caenorhabditis
elegans leads to an overall increase in H3K9me2 and
affects body movement (11).
It has also been proposed that PHF8 affects cell cycle
progression by facilitating E2F1-mediated transcriptional
activation (15) and that PHF8 co-activates rRNA tran-
scription (18,19). Although it is well established that
PHF8 alters gene expression, it is still unclear how
PHF8 mutations lead to XLMR. Indeed, the PHF8-
regulated gene expression changes are subtle; this
suggests that not only a single gene pathway is responsible
for the PHF8 phenotype but also a combination of
modiﬁcation may underlie this condition. Our results
show that PHF8 controls the expression of some key regu-
lators of the cytoskeleton such as RhoA, Rac1 and
GSK3b. Depletion of PHF8 has a striking effect on
cellular cytoskeleton structure and impairs neurite elong-
ation. These ﬁndings suggest that the XLMR phenotype
associated with PHF8 mutations could be due to alter-
ations in the cytoskeleton structure.
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MATERIALS AND METHODS
Cell culture, transfections and co-immunoprecipitation
assays
HeLa, HEK293T and SH-SY5Y cells were grown
under standard conditions (20). CoIP experiments with
transfected proteins were performed as described else-
where (21).
Primary neuronal cultures were prepared from cerebral
cortices of E17 mouse, sliced into 1-mm pieces and treated
with trypsin (0.05%, for 20min at 37C; Invitrogen). The
tissue was mechanically dissociated by passing through a
ﬂame-polished Pasteur pipette. Cells were plated at 1 104
cells/cm2 on poly-D-lysine-coated (0.5mg/ml) plates and
maintained in Neurobasal basal medium (Invitrogen) sup-
plemented with B27 (Invitrogen), penicillin/streptomycin
and glutamine at 2mM.
Plasmids
PHF8-HA was kindly provided by Dr Christoph Loenarz,
Flag-N-Myc by Dr Elisa Martı´ and Flag-c-Myc by Dr
Keiichi Nakayama. Flag-E47 has been previously
described (22). mPhf8 cDNA was cloned into pCDNA3
vector and the mutant HD>AA was generated using the
QuickChange II XL Site-Directed Mutagenesis kit
(Stratagene). The residues H247 and D249 at the jumonji
domain were mutated to A. Finally, it was cloned into the
polycistronic vector pCIG that co-expresses green
ﬂuorescent protein (GFP).
Viral vectors were purchased from Sigma: pLKO-
hPHF8#1 (GCAGGTAAATGGGAGAGGTTT),
pLKO-hPHF8#2 (CGAACCGTACAGCTCATTAAA),
pLKO-mPhf8-GCGGACTGTACAGCTCATTAA and
pLKO-random (CAACAAGATGAAGAGCACC). Tran-
sient KD in HeLa cells was performed using the pSuper
vector with a non-speciﬁc sequence (GGCTGAATGCAA
GCGTGGA) or one speciﬁc to the human PHF8 sequence
(GAGGAGAAGGCTGCTGACA).
Antibodies and reagents
Antibodies used were anti: PHF8 (Abcam ab36068),
c-Myc (Santa Cruz Biotechnology sc-764), HA (Sigma
H6908), FLAG M2 (Sigma F3165), H4K20me1 (Abcam
ab9053), b-catenin (Sigma C7207) and b-tubulin
(Chemicon MAB3408). Fibrillar actin was stained with
phalloidin–rhodamine (Sigma P1951).
Microarray analysis
RNAs from 106 HeLa cells were supplied to the
Microarrays Unit of the Center for Genomic Regulation
(CRG, Barcelona, Spain) for quality control, quantiﬁca-
tion, reverse transcription, labelling and hybridization
using an Illumina Platform with Whole Human Genome
microarrays. Triplicates were analysed for each sample.
Fold changes (FCs) between control and PHF8-depleted
samples were calculated applying the Array File Maker
4.0 (AFM 4.0) toolbox (23). Brieﬂy, differential expression
analysis was performed on non-control probes with an
empirical Bayes approach on linear models (Limma)
(24), and the results were corrected for multiple testing
according to the false discovery rate (25). Normalized
data are available at the Gene Expression Omnibus
database (http://www.ncbi.nlm.nih.gov/geo/) with the ac-
cession number GSE38175.
ChIP-Seq analysis
PHF8 ChIP-Seq data were downloaded from Gene
Expression Omnibus database (GSM531964) (16) and
analysed with the ChIP-Seq Tool Set (26) in order to
obtain PHF8 target genes and the peak intensity.
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were per-
formed using previously described procedures with few
modiﬁcations (27). Fixation with 1% formaldehyde was
stopped by the addition of 0.125mM glycine. Cytoplasms
were lysed with cell lysis buffer (20mM Tris–HCl pH 8,
85mM KCl, 0.5% NP40). Nuclei were isolated by centri-
fugation at 5000 rpm and resuspended in nuclei lysis
buffer (1% sodium dodecyl sulphate (SDS), 10mM
ethylenediaminetetraacetic acid (EDTA) and 50mM Tris
pH 8). The sonication step was performed in a Bioruptor
sonicator (to obtain 500 bp fragments) and 0.1mg of
protein was diluted in IP buffer (1% Triton, 2mM
EDTA, 150mM NaCl and 20mM Tris pH 8) for each
immunoprecipitation. The antibody–protein complex
was captured using pre-blocked protein A (Millipore
16-157) and DNA puriﬁcation performed using phenol/
chloroform. Finally, ChIP DNA was analysed by
quantitative polymerase chain reaction (qPCR). with
SYBR Green (Roche) in a LightCycler 480 PCR system
(Roche). For re-ChIP experiments, 0.3mg of protein was
used as starting material. After the ﬁrst ChIP with
anti-PHF8 antibody, protein–DNA complexes were
eluted in 50 ml 10mM Dithiothreitol (DTT) for 30min at
37C, diluted in IP buffer and subjected again to the ChIP
procedure with anti-c-Myc antibody.
Percentage of input was calculated from speciﬁc
immunoprecipitation enrichment values obtained by
qPCR with respect to the total starting chromatin (that
is the input material).
Immunoblotting
Immunoblotting was performed by standard procedures
and visualized on an Odyssey Infrared Imager (Li-Cor).
Messenger RNA extraction and qPCR
TRIZOL reagent (Invitrogen) was used to extract messen-
ger RNA (mRNA), following the manufacturer’s instruc-
tions. Reverse transcription was then performed with a
Transcription kit (Roche) following the manufacturer’s
procedure, and qPCR was performed with SYBR Green
(Roche) in LightCycler 480 (Roche).
Indirect immunoﬂuorescence
Cells were ﬁxed for 20min in 4% paraformaldehyde and
permeabilized with Phosphate buffered saline–Triton
0.1%. Indirect immunoﬂuorescence was performed as
described previously (21).
9430 Nucleic Acids Research, 2012, Vol. 40, No. 19
 at CSIC on D
ecem
ber 3, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Lentiviral transduction
HEK293T cells growing in a 10-cm dish were transfected
with a mix of packaging, envelop and short hairpin RNA
(shRNA) transfer vector DNAs (6, 5 and 7 mg, respect-
ively). After 30 h of transfection, the medium was collected
and the virus concentrated by ultracentrifugation
(26 000 rpm, 2 h at 4C). Viral particles were then added
to receptor cells. After 24 h, transduced cells were selected
with puromycin (HeLa: 5 mg/ml, SH-SY5Y: 0.5mg/ml).
Cortical neurons were infected when plated; viruses were
removed 24 h later and neurons were cultured for another
3 days before use. Instead of selection, viruses were added
to infect an 80% of the cells. Finally, the efﬁciency of KD
constructs was assessed by qPCR and immunoblot.
Plasmids were purchased from Sigma.
Neurite length quantiﬁcation
Pictures were taken of 10 randomly selected ﬁelds of phal-
loidin–rhodamine and 40,6-diamidino-2-phenylindole
(DAPI) stained SH-SY5Y and cortical cells. The total
length of neurites was calculated by using ImageJ
software, and related to total number of cells (quantiﬁed
by DAPI).
Statistical analysis
Quantitative data were expressed as mean and standard
deviation (SD) of at least three biologically independent
experiments. The signiﬁcance of differences between
groups was assessed using Student’s t-test (*P< 0.05;
**P< 0.01; ***P< 0.001).
RESULTS
PHF8 regulates cytoskeleton and cell adhesion gene
expression
To understand how PHF8 might contribute to XLMR, we
set out to identify genes whose regulation was
compromised in the absence of PHF8. To this end, we
performed a microarray expression experiment with
control and PHF8-depleted HeLa cells transiently trans-
fected with a random shRNA or with a PHF8 shRNA,
which efﬁciently decreases PHF8 levels (Figure 1A). The
RNA was extracted, labelled and hybridized to Illumina
gene expression arrays. Then, we selected genes showing
FCs 1.2 and 1.2 with an adjusted P-value 0.05
between the two conditions. We identiﬁed 259 (55%)
up-regulated and 211 (45%) down-regulated genes in
PHF8-depleted cells (Figure 1B) relative to control cells.
Microarray results were veriﬁed by using qPCR to check
12 genes with different FC and P-values (Figure 1C and
Supplementary Figure S1A). The mRNA levels of PHF8
homologs, KIAA1718 and PHF2, also were checked to
conﬁrm that the shRNAs did not affect the expression
of these genes (Supplementary Figure S1B). In order to
conﬁrm the speciﬁcity of the used shRNA, we performed
two experiments: (i) ﬁrst, we knocked down PHF8 with a
second independent PHF8 shRNA (Supplementary
Figure S1C) and checked by qPCR the expression of
the same set of genes. The results in Supplementary
Figure S1D showed that the expression of the analysed
genes was also affected; (ii) second, over-expression
of murine Phf8 (mPhf8) protein (Supplementary
Figure S1E), resistant to the human PHF8 shRNA,
restored the expression of most of the analysed genes
(Figure 1C, green boxes).
To further characterize the transcriptional differences
between control and PHF8-depleted cells, we assessed
the molecular and cellular functions over-represented in
the identiﬁed PHF8-dependent genes using Ingenuity
Pathway Analysis (Ingenuity Systems). We found that
the groups with the most signiﬁcant enrichment of
down-regulated genes or the total set of PHF8-regulated
genes were associated with cellular morphology and
dynamics (Figure 1D, upper panel and Supplementary
Figure S1F). In particular, several genes involved in the
Rho signalling pathway (RhoA, Rac1, mDia1) and in cell–
cell contact (a-catenin) were severely affected by PHF8
depletion. These functional categories were not
over-represented in the up-regulated genes (Figure 1D
lower panel). These data suggest that the ability of
PHF8 to regulate genes associated with cellular morph-
ology and dynamics might be linked to the transcriptional
co-activator function described for PHF8 (11,12). Further,
genes involved in cell growth and proliferation are also
signiﬁcantly enriched (as previously shown) (15). In line
with this, cell growth defects were observed in
PHF8-depleted cells (Supplementary Figure S2).
Comparison of our results with genome-wide localization
of PHF8-binding sites along the genome performed in
HeLa cells (16) indicated that 51% of the genes differen-
tially expressed in the microarray (deregulated) were
PHF8 direct targets; from these, 62% were down-
regulated and 38% up-regulated (Figure 1E and Supple-
mentary Figure S3A). In contrast, only 15% of non-
deregulated genes were bound by PHF8 (Figure 1E). On
the other hand, 3% of PHF8 target genes identiﬁed by
ChIP-Seq (16) were differentially expressed upon PHF8
KD, in concordance with previous results showing that
few PHF8 target genes were transcriptionally affected by
PHF8 depletion (11). In agreement with our previous
data, analysis of the molecular and cellular functions
over-represented in the identiﬁed PHF8-direct target and
deregulated genes indicated that the cellular morphology
and dynamics groups were again signiﬁcantly enriched
(Supplementary Figure S1G). In order to understand
why few PHF8 target genes were differentially expressed
upon PHF8 depletion, we compared PHF8-binding inten-
sity (detected by ChIP-Seq) between different sets of
genes. The results in Supplementary Figure S3B and C
showed that there were no signiﬁcant differences in
PHF8-binding intensity between deregulated and
non-deregulated genes or between up- and down-regulated
genes in the microarray.
PHF8 reduction leads to cytoskeleton disorganization and
cell adhesion alterations
Based on the aforementioned results and because the
PHF8-associated phenotype (XLMR with or without
CL/P) is related to cell adhesion and cytoskeleton
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organization (1,28,29), we sought to investigate whether
PHF8 could regulate these processes. To this end, we
established two PHF8 KD lines of HeLa cells by trans-
duction with lentiviral particles containing PHF8
shRNA (PHF8 KD) or a random shRNA sequence
(Control KD). Immunoblot analysis conﬁrmed that
PHF8 shRNAs efﬁciently decrease the PHF8 protein,
although to different degrees (line#1 had lower levels
than #2) (Figure 2A) without affecting the expression
levels of the PHF8 homologs, KIAA1718 and PHF2
(Supplementary Figure S4A and B). Then, we analysed
the effects of PHF8 depletion on cytoskeleton structure
and cell adhesion. To this end, Control and PHF8 KD
cells were stained with phalloidin–rhodamine and
b-catenin antibody. The results in Figure 2B showed a
strong effect of PHF8 depletion on cellular structure.
Phalloidin staining revealed that control cells are polyg-
onal, and they are strongly bound together (Figure 2B
and C-i, ii). The cytoskeleton is disorganized in PHF8
KD cells and they are more rounded and less ﬂat than
Control KD cells (Figure 2B, and C-iii, iv). In addition,
PHF8 KD cells have more ﬁlopodia than control cells
(Figure 2B and 2C-v, vi). Moreover, b-catenin staining
evidences that cell–cell contact is partially lost (Figure
2B). In order to conﬁrm that the observed phenotype is
due to PHF8 activity, we used a PHF8 mutant that
lacks HDM activity (PHF8 HD>AA, see ‘Materials
and Methods’ section) (5). Over-expression of this
inactive protein (Supplementary Figure S1E) resulted
in an increased number of the rounded cells (from
19% in GFP over-expressing cells to 62.6% in PHF8
HD>AA) (Figure 2D).
As many of the identiﬁed gene products are involved in
focal adhesion, we analysed the ability of PHF8-depleted
cells to attach to the substrate. To that end, the same
numbers of Control KD and PHF8 KD#1 (from now
on PHF8 KD) cells were plated and the number of
attached cells was quantiﬁed at different time points
Figure 1. PHF8 regulates cytoskeleton and cell adhesion gene expression. (A) PHF8 was depleted from HeLa cells with a speciﬁc shRNA. A random
shRNA was used as a control. Total cell lysates were immunoblotted with anti-PHF8 and anti-b tubulin as a loading control. (B) Diagram showing
the number and percentage of up- and down-regulated genes in the microarray expression analysis. (C) Some selected genes in the microarray were
validated by qPCR. The data were normalized by 18S mRNA levels. Error bars indicate SD (D) The genes in the microarray were analysed with
Ingenuity Pathway Analysis. The chart shows the over-represented biological functions for down-regulated (upper panel) and up-regulated genes
(lower panel). (E) Diagrams showing the number and percentage of differentially expressed genes in the microarray (PHF8 regulated genes) that are
PHF8 direct targets in ChIP-Seq experiments (right panel). The percentage of PHF8 non-regulated genes that are bound by PHF8 is shown on the
left panel.
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(by quantifying crystal violet-stained cells after ﬁxing).
Pictures taken at different times showing that PHF8 KD
cells take longer to attach to the substrate (Figure 2E).
Quantiﬁcation indicated that 2 h after plating, Control
KD cells began to attach (27.8% cells attached), while
PHF8 KD cells were less able to bind (5% cells
attached). These differences were maintained for 4 h
(41.9% of control cells had become attached while
only 16.4% of PHF8 KD cells had bound to the plate)
(Figure 2E). After 10 h, almost all cells were attached to
the plate in both cases. Taken together these data suggest
that PHF8 depletion leads to a strong alteration in cell
structure and dynamics. Moreover, they indicate that
PHF8 HDM activity is required for the proper cell struc-
ture organization.
PHF8 directly regulates cytoskeleton-related genes
At this point, our data suggested that PHF8 played an
essential role in regulating cytoskeleton gene expression.
To understand how PHF8 might contribute to this tran-
scriptional control, we tested whether these genes are
direct targets of PHF8. To this end, we performed ChIP
experiments in Control and PHF8 KD cells and analysed
the promoters of a subset of genes by qPCR. We selected
some genes that were down-regulated in the microarray
experiment and that are essential for deﬁning cell structure
and dynamics: RhoA, GSK3b and a-catenin. The results,
illustrated in Figure 3A, demonstrated that PHF8 is
bound to the TSS region of the analysed promoters but
not to control promoters: OLIG2 (an inactive gene) and
Figure 2. PHF8 KD cells have disorganized actin cytoskeleton and adhesion defects. (A) Immunoblot from Control KD, PHF8 KD#1 and PHF8
KD#2 cell extracts using the indicated antibodies. (B) Control and PHF8 KD cells were stained with phalloidin–rhodamine and anti-b-catenin to
visualize the cytoskeleton structure and cell–cell contacts. The number of round cells in each sample was quantiﬁed by direct counting in different
experiments. Data show mean of n=500 cells. Error bars indicate SD *P< 0.05; **P< 0.01. The percentage of total cells counted is represented. (C)
Details of the cytoskeleton structure of Control and PHF8 KD cells. (D) HeLa cells were transfected with pCIG (GFP) or pCIG-PHF8 HD>AA
(PHF8 HD>AA). Then, cells were stained with phalloidin–rhodamine and DAPI. Transfected cells (GFP positive) were analysed. The number of
green and round cells was quantiﬁed by direct counting. Data show mean of n=100 cells. Error bars indicate SD *P< 0.05; **P< 0.01. (E) Pictures
of Control and PHF8 KD cells were taken at different times after seeding. Cells were ﬁxed and stained with crystal violet at different times after
seeding. The intensity of the staining was quantiﬁed with ImageJ software. Results are the mean of three independent experiments. Data show mean
of n=700 cells. Error bars indicate SD.
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PSMB4 (an active gene). As PHF8 is a HDM for
H4K20me1, we compared the levels of this histone modi-
ﬁcation at the analysed promoters in Control and PHF8
KD cells. The results shown in Figure 3B indicate that
methylation increases at the promoter level after PHF8
depletion. These data strongly suggest that PHF8
directly regulates the expression of the analysed genes.
PHF8 cooperates with Myc transcription factor to
regulate transcription
Next, we sought to investigate how PHF8 is targeted to
cytoskeleton gene promoters. To do that, we analysed the
promoter sequences of genes whose expression is affected
by the depletion of PHF8 identiﬁed in the microarray ex-
periment using the PEAKS tool (30). We checked 400 bp
upstream and 200 downstream of the TSS. Binding sites
(with a P-value lower than 1 e-18) for E2F1, Sp1, Foxo1,
TCF and Myc-Max among others were identiﬁed
(Supplementary Figure S5A). As c-Myc transcription
factor has recently been reported to be a key regulator
of RhoA expression (31), and PHF8 cooperates with
c-Myc in transcriptional activation (12), we decided to
investigate whether Myc could contribute to PHF8-
mediated transcriptional regulation of the analysed
genes. To address this question, we ﬁrst decreased transi-
ently the c-Myc protein levels of HeLa cells by transduc-
tion with lentiviral particles containing c-Myc shRNA
(c-Myc KD). Immunoblot analysis conﬁrmed that c-Myc
shRNA decreases c-Myc protein while PHF8 levels were
not affected (Figure 4A). Then, we determined by qPCR
the mRNA levels of RhoA, GSK3b and a-catenin in cells
transduced with control and c-Myc shRNAs. The results
shown in Figure 4B indicate that c-Myc is essential for an
efﬁcient transcription of the analysed PHF8-regulated
genes. Then, we sought to determine whether c-Myc
binds the analysed gene promoters. Our ChIP results in
Figure 4C demonstrate that c-Myc factor efﬁciently binds
RhoA, GSK3b and a-catenin promoters in Control cells,
but not in c-Myc KD cells. The results described above
demonstrate that c-Myc and PHF8 regulate and bind to
the same set of genes, thus we tested whether c-Myc and
PHF8 bind simultaneously to the same nucleosomes. To
address this question, we performed re-ChIP experiments,
immunoprecipitating sequentially PHF8 and c-Myc
factors from HeLa cells. Figure 4D shows a signiﬁcant
enrichment of PHF8 and c-Myc factors on RhoA and
a-catenin promoters after both immunoprecipitations,
suggesting that these proteins bind simultaneously to
some promoters.
Given this, we wondered whether c-Myc is required for
PHF8 recruitment to RhoA, a-catenin and GSK3b pro-
moters. To address this question, we ﬁrst compared the
binding of c-Myc in Control, PHF8 KD and c-Myc KD
cells using ChIP assays. Our results showed that c-Myc
binds to the promoters in Control and PHF8 KD cell
lines (Figure 4E). Then, we checked the binding of
PHF8 in Control, c-Myc KD and PHF8 KD cells.
Figure 4F shows that PHF8 binding to promoters
observed in Control cells was signiﬁcantly reduced in
c-Myc KD cells, suggesting that c-Myc is required for
Figure 3. PHF8 demethylates H4K20me1 at promoters. (A) ChIPs of PHF8 in Control and PHF8 KD cells analysed by qPCR, at the TSS of the
indicated genes. (B) ChIP of H4K20me1 in Control and PHF8 KD cells. Results are the mean of three independent experiments. Error bars indicate
SD *P< 0.05; **P< 0.01.
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Figure 4. PHF8 and c-Myc cooperate to regulate the expression of the same genes. (A) Immunoblot of c-Myc, PHF8 and b-tubulin in Control and
c-Myc KD HeLa cells. (B) mRNA levels of several PHF8-dependent cytoskeleton and cell adhesion genes in c-Myc KD cells quantiﬁed by qPCR.
The data were normalized by 18S mRNA levels. Results are the mean of two independent experiments. Error bars indicate SD (C) ChIPs of c-Myc in
Control and c-Myc KD cells analysed by qPCR at the indicated promoters. (D) Re-ChIP experiments in HeLa WT cells. After the ﬁrst ChIP with
anti-PHF8 antibody, protein–DNA complexes were eluted and immunoprecipitated with anti-c-Myc antibody. (E) ChIPs of c-Myc analysed by
qPCR at the promoter of several genes in Control KD, PHF8 KD and c-Myc KD cell lines. (F) ChIPs of PHF8 in Control KD, c-Myc KD and
PHF8 KD cell lines. Results are the mean of three independent experiments. Error bars indicate SD *P< 0.05; **P< 0.01. (N.S.) Non-signiﬁcant.
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PHF8 binding to the analysed promoters. Given that
PHF8 binds to H3K4me3 nucleosomes through its PHD
domain (11,12), we tested whether the lower binding in
c-Myc KD cells was due to a decrease in H3K4me3 level
after c-Myc depletion. ChIP experiments in Control and
c-Myc KD cells showed no differences in H3K4me3 level
between the two cell lines (Supplementary Figure S5B).
These data are in concordance with previous results
showing that MLL (the enzyme that trimethylates
H3K4) recruitment to promoters is previous to Myc
binding (32). Taken together, these results indicate that
c-Myc contributes to PHF8 targeting to some cytoskel-
eton gene promoters but not vice versa. Finally, we
checked whether PHF8 and Myc proteins are able to
interact. Co-immunoprecipitation (Co-IP) experiments
with over-expressed proteins indicated that PHF8 inter-
acts with both c-Myc and N-Myc (the neural Myc
form), but not with another bHLH factor (E47)
(Supplementary Figure S5C). However, we did not
detect binding of the endogenous proteins under the
studied conditions in agreement with previous data (12).
All together our results indicate that PHF8 forms part
of the Myc-mediated transcriptional complex that regu-
lates the activity of some genes involved in cell structure
and dynamics.
Down-regulation of PHF8 leads to alterations in
neurite outgrowth
The elongation and guidance of neurites as well as the
formation of dendritic spines require the integration of
cell signalling and gene transcription events (29,33).
Alterations of cytoskeleton molecules in neuronal cells
affect the structure and function of dendritic spines,
synapses and axon elongation. In line with that, changes
in the activity of the small GTPases RhoA and Rac1 have
been associated with mental retardation disorders
(29,34,35).
Due to the essential role of cell adhesion and cytoskel-
eton molecules in the function of neuronal circuits, we
analysed whether low levels of PHF8 could affect
neurite outgrowth. To test this hypothesis, the levels of
PHF8 were transiently reduced in the neuroblastoma cell
line SH-SY5Y and the presence of neurites was monitored
by phalloidin staining. Supplementary Figure S6A shows
that transfected cells lose neurites and the actin cytoskel-
eton collapses. In order to conﬁrm these results, SH-SY5Y
cell line was infected with lentivirus expressing two differ-
ent shRNAs against PHF8 or the control shRNA. In
agreement with our previous results, cells with low levels
of PHF8 were more rounded and less ﬂat than Control
KD cells, they formed foci and replicated very slowly
(Figure 5A). The PHF8 KD#1 cells were not able to pro-
liferate and so all the experiments were performed in
PHF8 KD #2 cell line. We ﬁrst checked the expression
of the analysed genes (RhoA, GSK3b and a-catenin)
and other down-regulated genes in the microarray
(Figure 1) required for neuritogenesis (Diaph1 and
Rac1). The expression of these genes was also PHF8-
dependent in SH-SY5Y cells (Figure 5B). Moreover,
Gene Ontology analysis of PHF8-direct target genes
identiﬁed by genome-wide analysis in the SH-SY5Y
cell line (11) showed that the most enriched categories
are ones related to cytoskeleton dynamics (Supplementary
Figure S6B).
Based on these results, we next sought to investigate the
ability of PHF8-depleted cells to form neurites using phal-
loidin staining. The results showed that the number and
length of neurites are markedly lower in cells with low
levels of PHF8 (Figure 5C). Finally, we investigated
whether PHF8-depleted cells elongated neurites upon
neuronal differentiation induced by retinoic acid treat-
ment. The results demonstrated that PHF8-depleted cells
have a limited ability to generate and to extend neurites
(Figure 5D). Moreover, over-expression of the catalytic-
ally inactive mutant PHF8 HD>AA altered the structure
of transfected cells (69%) when compared with GFP-
transfected cells (39%) (Figure 5E). This result suggests
that PHF8 HDM activity is required for neuritogenesis.
As PHF8 is highly expressed in cerebral and cerebellar
cortex (10), we sough to conﬁrm our results in primary
neuronal cultures derived from the mouse cerebral cortex
(see ‘Materials and Methods’ section). In order to reduce
PHF8 levels, cortical neurons were infected with lentivirus
expressing shRNA against mPhf8 or the control shRNA,
and the length and morphology of neurites were monitored
by phalloidin staining at 4DIV (Days in vitro) (Figure 6).
mPhf8 down-regulation was conﬁrmed by checking the
mRNA levels by qPCR (Figure 6A). Neurons with low
levels of mPhf8 showed a general alteration of the cellular
morphology (Figure 6B-i and iv). In particular, the number
of neurites per cell was clearly reduced when compared with
neurons expressing the control shRNA, going from 4–5 in
control to 2–3 in mPhf8 KD neurons (Figure 6B ii and v;
quantiﬁed in Figure 6C). Interestingly, in mPhf8 KD
cultures, a high number of cells presented only a single or
none neurites (Figure 6B v and Figure 6C). In addition, the
neurite length was also reduced (Figure 6B iii and vi;
quantiﬁed in Figure 6D). A dramatic effect of mPhf8 de-
pletion on neurite structure was also observed at the growth
cones: they were not well deﬁned and presented ﬁlopodia in
different directions, resulting in wider neurites than in
control neurons (arrows in Figure 6B v-vi). Furthermore,
the number and length of secondary neurites were also
reduced in mPhf8 KD cells (Figure 6B). As a consequence
of both, a reduced length and number of neurites, the
connexions between neighbouring neurons were also
affected in KD PHF8 compared with control neurons. In
accordance with these results, over-expression of PHF8
HD>AA did not allow the growth and branching of
neurites (Figure 6E).
Overall, these results suggest that PHF8 is essential for
normal growth and stabilization of neurites during
neuritogenesis. Accordingly, low levels or complete loss
of function of PHF8 could lead to impaired neuronal
connections.
DISCUSSION
XLMR is a complex set of disorders in which a large
number of genes are involved; this makes it very difﬁcult
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to understand the molecular mechanisms responsible for
this type of mental retardation. Our work links histone
modiﬁcations, cytoskeleton structure and processes
affected in this type of mental retardation. We demon-
strate that PHF8, together with c-Myc, is recruited to
promoters of genes involved in the maintenance of cyto-
skeleton structure. This is essential to facilitate neurite
formation and/or maintenance in neuronal cells.
We demonstrate that PHF8 and Myc transcription
factor bind to the same promoter regions of some target
genes and that PHF8 binding is reduced after Myc deple-
tion; these data suggest than Myc might be involved in the
initial targeting of PHF8 to the analysed promoter. Other
factors, such as ZNF711 (11) and E2F1 (15), interact with
PHF8 and facilitate its targeting to the promoters. These
data point to the possibility that proteins that directly
bind chromatin could play a role in the recruitment of
PHF8 to common promoters. On the other hand, it has
previously been shown that the H3K4me3 mark is
involved in the recruitment of PHF8 to promoters.
Then, after the initial targeting by the interaction
between transcription factors and PHF8, the association
of PHF8 with the histone tail may contribute to stabilize
the binding and to facilitate efﬁcient catalytic activity.
We have been unable to detect an increase in overall
H4K20me1 levels upon PHF8 down-regulation (data not
shown), suggesting that the recruitment of a speciﬁc
H4K20 methyltransferase is not a default mechanism in
the cell types analysed. On the other hand, our results
have shown that depletion of PHF8 leads to a local
increase in H4K20me1 levels that correlates with an inef-
ﬁcient transcription. These data suggest that the
Figure 5. PHF8 is required for neurite elongation in SH-SY5Y cells. (A) Transmitted light photographs showing the morphology of SH-SY5Y cells
stably transduced with lentiviral particles containing PHF8 shRNAs (PHF8 KD) or a random shRNA (Control KD). (B) mRNA levels of PHF8
target genes in Control and PHF8 KD SH-SY5Y cells. The data were normalized by 18S mRNA levels. Results are the mean of two independent
experiments. Error bars indicate SD (C) Control and PHF8 KD cells stained with DAPI, phalloidin–rhodamine and anti-PHF8 antibody.
Quantiﬁcation of the total neurite length relative to the total number of cells, using ImageJ software. Data show mean of n=300 cells. Error
bars indicate SD *P< 0.05. (D) Control and PHF8 KD cells treated with retinoic acid 10 mM (RA) for 48 h stained with DAPI, phalloidin–
rhodamine and anti-PHF8 antibody. Quantiﬁcation of the total neurite length relative to the total number of cells after RA treatment. Data
show mean of n=300 cells. Error bars indicate SD **P< 0.01. (E) SH-SY5Y cells were transfected with pCIG (GFP) or pCIG-PHF8 HD>AA
(PHF8 HD>AA). Then, cells were stained with phalloidin–rhodamine. Transfected cells (GFP positive) were analysed. The phenotype of
GFP-positive cells was quantiﬁed by direct counting. Data show mean of n=100 cells. Error bars indicate SD **P< 0.01.
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demethylase activity on H4K20me1 plays a role regulating
transcription.
Our analyses have identiﬁed PHF8-regulated genes
related to cell growth as previously described (15) and
also many genes involved in cell structure and dynamics
(Figure 1); namely, several components of the Rho
GTPase signalling pathway (Rac1, RhoA, Diaph1),
catenins (a-catenin) and its regulators (GSK3b), among
others. Rho GTPases are key signalling proteins that
function integrating extracellular and intracellular
signals to regulate the actin cytoskeleton (33); in particu-
lar, they regulate the changes in the cytoskeleton required
for neurite outgrowth and the regulation of synaptic con-
nectivity (36,37). In line with this, mutations that alter
Rho GTPase signalling result in abnormal neuronal con-
nectivity and deﬁcient cognitive functioning in humans
(29,34). Given this, any disturbance of Rho GTPase
signalling due to alterations in expression and/or regula-
tion would have important consequences for cell physi-
ology and function. During development, this could
affect neurite outgrowth and branching as well as the
guidance of axons and dendrites, leading to deﬁciencies
in neuronal network connectivity characteristic of
mental retardation (38). Moreover, in mature neurons
dynamics change in neuronal cytoskeleton is also essen-
tial to respond to environmental cues. Both abilities,
initial dendritic formation and dendritic plasticity, are
dependent on actin cytoskeleton that is controlled by
Rho GTPases (36,39,40). On the other hand, the dendritic
plasticity in the mature nervous system is the basis for
learning and memory functions affected in MR.
However, the mechanisms responsible for the alteration
of Rho GTPase activity in MR have not been completely
explored.
Recently, epigenetic factors are emerged as master regu-
lators of many key cellular functions, and then alteration
of their function leads to serious pathologies. Our data
show that the HDM PHF8 controls the expression levels
of some essential Rho GTPase signalling components,
providing a good model to study the molecular
Figure 6. Cortical neurons require PHF8 for proper neurite outgrowth. (A) mRNA levels of mPhf8 in Control and Phf8 KD cortical neurons,
normalized by Gapdh mRNA levels. Results are the mean of two independent experiments. Error bars indicate SD (B) Control and Phf8 KD cortical
neurons stained with phalloidin–rhodamine and DAPI. (C) Number of dendrites per cell was quantiﬁed by direct counting of 10 randomly selected
ﬁelds. Data show mean of n=500 cells. Error bars indicate SD between ﬁelds. **P< 0.01. (D) Neurite length of 500 cells was quantiﬁed using
ImageJ software. Data show mean of n=500 cells. Error bars indicate SD ***P< 0.001. (E) Cortical neurons cells were transfected with pCIG
(GFP) or pCIG-PHF8 HD>AA (PHF8 HD>AA). Then, cells were stained with DAPI. The morphology of transfected cells was followed by GFP
signal.
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mechanisms involved in XLMR due to low levels of Rho
activity. On the other hand, understanding the molecular
steps in the development of cognitive defects in MR will
allow pharmacologic action with drugs to improve the
cognitive function. Such a treatment could be directed to
promote neurite outgrowth and normal dendritic spine
number and function.
In summary, our study has revealed that PHF8 plays a
key role regulating the expression of Rho GTPase
signalling molecules. Accordingly, low levels of PHF8
result in deﬁcient neurite outgrowth and stabilization.
Overall, our results suggest that the mental retardation
phenotype associated with loss of function of PHF8
could be due to abnormal neuron connections as a result
of alterations in cytoskeleton function.
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